Suggestions to preclude ARHL, AD and AD-related amyloid cardiomyopathy through timely treatment of SGN loss by neurotrophin supplementation has become an important topic in potential treatments of AD and its comorbidities. Here, BDNF is linked to cardiac amyloidosis.